RK
Ravi Kant Litoria
About Ravi Kant Litoria
Data last updated:
Ravi Kant Litoria is a Director at Risesun Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Risesun Pharmaceutical Private Limited reported revenue of ₹2.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Risesun Pharmaceutical Private Limited U21004MP2023PTC065251 | Director | 12 Apr 2023 | 2023 | ₹2.8 Lakh (FY 2025) | Active |
Board colleagues of Ravi Kant Litoria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Rajoriya | 10114162 | Risesun Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kant Litoria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kant Litoria
Ravi Kant Litoria currently holds 1 directorship: Risesun Pharmaceutical Private Limited (Director, since 12 Apr 2023, revenue ₹2.8 Lakh (FY 2025)).
Ravi Kant Litoria was first appointed on 12 Apr 2023 as Director at Risesun Pharmaceutical Private Limited.
The current boards of Ravi Kant Litoria's companies include Anil Rajoriya (Risesun Pharmaceutical Private Limited).